Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$627M |
| 2 |
Baidu
BIDU
|
+$542M |
| 3 |
iShares MBS ETF
MBB
|
+$492M |
| 4 |
NVIDIA
NVDA
|
+$429M |
| 5 |
Comcast
CMCSA
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.29B |
| 2 |
DuPont de Nemours
DD
|
+$635M |
| 3 |
Broadcom
AVGO
|
+$398M |
| 4 |
Eli Lilly
LLY
|
+$394M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.86% |
| 2 | Healthcare | 3.34% |
| 3 | Consumer Discretionary | 2.41% |
| 4 | Financials | 2.35% |
| 5 | Industrials | 1.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
2026
DELISTED
ChemoCentryx, Inc.
CCXI
| $17.6M | ﹤0.01% |
343,380
-229,691
| -40% | -$13.8M |
|
|
FMIVU
2027
DELISTED
Forum Merger IV Corporation Unit
FMIVU
| $17.6M | ﹤0.01% |
+1,776,717
| New | +$17.7M |
|
2028
Arista Networks
ANET
$251B
| $17.6M | ﹤0.01% |
931,056
-1,017,824
| -52% | -$19M |
|
2029
PUT
Aptiv
APTV
$10.3B
| $17.6M | ﹤0.01% |
127,400
+3,600
| +3% | +$523K |
|
2030
PUT
C.H. Robinson
CHRW
$17.4B
| $17.6M | ﹤0.01% |
184,000
-85,100
| -32% | -$7.95M |
|
2031
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $17.5M | ﹤0.01% |
560,400
-2,119,555
| -79% | -$65.4M |
|
|
ACH
2032
Accendra Health
ACH
$73.1M
| $17.5M | ﹤0.01% |
466,682
-1,082,737
| -70% | -$33.9M |
|
2033
PUT
AngloGold Ashanti
AU
$48.7B
| $17.5M | ﹤0.01% |
797,800
+574,700
| +258% | +$12.9M |
|
|
SNCY
2034
DELISTED
Sun Country Airlines
SNCY
| $17.5M | ﹤0.01% |
+511,061
| New | +$17.3M |
|
|
MNDT
2035
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $17.5M | ﹤0.01% |
894,500
+78,600
| +10% | +$1.64M |
|
2036
Franklin Resources
BEN
$17.2B
| $17.5M | ﹤0.01% |
591,281
-1,646,350
| -74% | -$45M |
|
|
ITOS
2037
DELISTED
iTeos Therapeutics
ITOS
| $17.5M | ﹤0.01% |
510,998
-286,316
| -36% | -$10.3M |
|
|
CYBR
2038
DELISTED
CyberArk
CYBR
| $17.4M | ﹤0.01% |
134,860
+132,857
| +6,633% | +$20.1M |
|
2039
CALL
Under Armour
UAA
$2.3B
| $17.4M | ﹤0.01% |
787,000
-103,100
| -12% | -$2.15M |
|
2040
CALL
Opendoor
OPEN
$3.53B
| $17.4M | ﹤0.01% |
850,433
+205,840
| +32% | +$5.44M |
|
2041
Alnylam Pharmaceuticals
ALNY
$30.6B
| $17.4M | ﹤0.01% |
123,226
+42,265
| +52% | +$6.36M |
|
2042
CALL
Synopsys
SNPS
$80.7B
| $17.4M | ﹤0.01% |
70,200
-25,900
| -27% | -$6.58M |
|
2043
Xylem
XYL
$27.9B
| $17.4M | ﹤0.01% |
165,125
+99,302
| +151% | +$10.1M |
|
2044
CALL
Innovative Industrial Properties
IIPR
$1.62B
| $17.4M | ﹤0.01% |
96,400
+1,300
| +1% | +$249K |
|
2045
CALL
XPO
XPO
$24.7B
| $17.3M | ﹤0.01% |
406,819
-707,813
| -64% | -$29.4M |
|
|
RDS.B
2046
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $17.3M | ﹤0.01% |
470,426
+276,334
| +142% | +$10.5M |
|
|
VRNT
2047
DELISTED
Verint Systems
VRNT
| $17.3M | ﹤0.01% |
380,841
+289,328
| +316% | +$12.9M |
|
2048
CALL
AGNC Investment
AGNC
$13B
| $17.3M | ﹤0.01% |
1,033,600
-8,900
| -0.9% | -$144K |
|
2049
Legend Biotech
LEGN
$3.95B
| $17.3M | ﹤0.01% |
596,714
+360,065
| +152% | +$9.82M |
|
2050
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
| $17.3M | ﹤0.01% |
337,169
+105,294
| +45% | +$5.42M |
|
Similar funds
Ken Griffin's Q1 2021 Portfolio in Review
As of Q1 2021, Ken Griffin held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q1 2021 filing shows 3,276 new, 5,445 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
- Ken Griffin added most to Amazon in Q1 2021, an estimated $627M increase.
- Ken Griffin's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
- Ken Griffin fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
- Ken Griffin's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
- Ken Griffin opened 3,276 new positions and closed 1,034 in Q1 2021.
- Ken Griffin's portfolio value rose 6% quarter-over-quarter to $408B.
Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.